posteditor

posteditor

Apnimed Announces Publication of its Phase 3 SynAIRgy Trial of AD109 for Obstructive Sleep Apnea in the American Journal of Respiratory and Critical Care Medicine

B Companion mechanistic review article published concurrently in the American Journal of Respiratory Cell and Molecular Biology in first-of-its-kind dual publications Publications reinforce AD109’s potential, if approved, as a first-in-class oral pill designed to improve oxygenation during sleep and target…